EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease

Mushood Ahmed, Areeba Ahsan, Aimen Shafiq, Raheel Ahmed, Mahboob Alam, Pierre Sabouret, Jamal S Rana, Gregg C Fonarow

Clinical Cardiology · 2024-10 · 47 (10)

DOI: 10.1002/clc.70026 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Cardiology, online erschienen am 07.10.2024. Verfasst von Mushood Ahmed und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Coronary Artery Disease, Fibrinolytic Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral anticoagulants (OACs) are routinely used for the management of atrial fibrillation (AF) while antiplatelet agents are used in coronary artery disease (CAD). However, data regarding the comparative clinical outcomes of OAC monotherapy versus dual antithrombotic therapy (anticoagulant plus antiplatelet agent) in patients with AF and stable CAD are limited.

Methods

A comprehensive search of major databases including PubMed/MEDLINE, Cochrane Library, and Embase was performed from inception to September 1, 2024 to identify randomized control trials (RCTs) that compared OAC monotherapy with dual antithrombotic therapy in patients with AF and stable CAD. The risk ratios (RRs) were estimated with corresponding 95% confidence intervals (CIs) for all outcomes.

Results

A total of three RCTs reported data for 3945 patients with AF and stable CAD. The mean age of patients was 73.8 (±11.85) years and the mean follow‐up was 22 months. OAC monotherapy was associated with a significantly reduced relative risk of major bleeding (RR: 0.55, 95% CI: 0.32–0.95) compared to dual therapy. The risk of all‐cause death (RR: 0.85, 95% CI: 0.49–1.48), cardiovascular death (RR: 0.84, 95% CI: 0.50–1.41), any stroke event (RR: 0.74, 95% CI: 0.46–1.18), and myocardial infarction (RR: 1.57, 95% CI: 0.79–3.12) remained comparable across the two groups.

Conclusion

OAC monotherapy led to a significant relative risk reduction for major bleeding with similar rates of ischemic events and mortality compared to dual antithrombotic therapy in patients with AF and stable CAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsAtrial FibrillationCoronary Artery DiseaseFibrinolytic AgentsHumansAdministration, OralDrug Therapy, CombinationHemorrhagePlatelet Aggregation InhibitorsRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

anticoagulantantiplateletatrial fibrillationcoronary artery disease

Substanzen

AnticoagulantsFibrinolytic AgentsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
  • Department of Medicine, Foundation University Medical College, Islamabad, Pakistan.
  • Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • Department of Cardiology, Royal Brompton Hospital, London, UK.
  • Department of Cardiology, National Heart and Lung Institute, Imperial College, London, UK.
  • Department of Cardiology, Baylor College of Medicine, Houston, Texas, USA.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Ahmed, M., Ahsan, A., Shafiq, A., Ahmed, R., Alam, M., Sabouret, P., Rana, J. S., & Fonarow, G. C. (2024). Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clinical Cardiology, 47(10). https://doi.org/10.1002/clc.70026

Vancouver

Ahmed M, Ahsan A, Shafiq A, Ahmed R, Alam M, Sabouret P, et al. Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clinical Cardiology. 2024;47(10). doi:10.1002/clc.70026

BibTeX
@article{Ahmed2024,
  author = {Ahmed, Mushood and Ahsan, Areeba and Shafiq, Aimen and Ahmed, Raheel and Alam, Mahboob and Sabouret, Pierre and Rana, Jamal S and Fonarow, Gregg C},
  title = {Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease},
  journal = {Clinical Cardiology},
  year = {2024},
  volume = {47},
  number = {10},
  doi = {10.1002/clc.70026}
}
Kostenlos starten →